Table 3 Breakthrough infections after mRNA vaccination
Patient | Age | Gender | Primary disease | Number of V | Days since last V (days) | Anti-spike antibody after 2 or 3 doses V (AU/mL) | Anti-spike antibody before BTI (AU/mL) | Severity of illness |
|---|---|---|---|---|---|---|---|---|
1 | 73 | F | DM | 2 | 219 | 19,000 | 597.9 | Mild·OP |
2 | 75 | M | DM | 3 | 70 | 4,919 | 61,000 | Mild·AD |
3 | 50 | F | NDM | 3 | 91 | 11,000 | 14,000 | Mild·OP |
4 | 53 | M | NDM | 3 | 137 | 18,000 | 11,000 | Mild·AD |
5 | 58 | M | NDM | 3 | 141 | 11,000 | 6,424 | Mild·OP |
6 | 73 | M | NDM | 3 | 131 | 1,693 | N.A | Mild·AD |
7 | 68 | M | NDM | 3 | 164 | 62,000 | 10,000 | Mild·AD |